VOR Stock Summary and Trading Ideas (Vor Biopharma | NASDAQ:VOR)

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Vor Biopharma trades on the NASDAQ stock market under the symbol VOR.

As of April 1, 2026, VOR stock price declined to $17.39 with 1,411,227 million shares trading.

VOR has a beta of 4.83, meaning it tends to be more sensitive to market movements. VOR has a correlation of 0.10 to the broad based SPY ETF.

VOR has a market cap of $849.46 million. This is considered a Small Cap stock.

In the last 3 years, VOR traded as high as $114.00 and as low as $2.62.

The top ETF exchange traded funds that VOR belongs to (by Net Assets): XBI, VTI, VXF, ITOT, LABU.

VOR has outperformed the market in the last year with a price return of +21.2% while the SPY ETF gained +18.5%. VOR has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +33.0% and +26.7%, respectively, while the SPY returned -3.6% and -2.1%, respectively.

VOR support price is $16.90 and resistance is $18.78 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VOR shares will trade within this expected range on the day.